Front Row Advisors’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $62.5K | Hold |
733
| – | – | 0.02% | 205 |
|
|
2025
Q4 | $57.9K | Hold |
733
| – | – | 0.02% | 207 |
|
|
2025
Q3 | $58.6K | Hold |
733
| – | – | 0.02% | 204 |
|
|
2025
Q2 | $66.6K | Hold |
733
| – | – | 0.02% | 189 |
|
|
2025
Q1 | $68.7K | Hold |
733
| – | – | 0.03% | 192 |
|
|
2024
Q4 | $66.6K | Hold |
733
| – | – | 0.02% | 197 |
|
|
2024
Q3 | $76.1K | Hold |
733
| – | – | 0.03% | 186 |
|
|
2024
Q2 | $71.1K | Hold |
733
| – | – | 0.02% | 230 |
|
|
2024
Q1 | $66K | Buy |
733
+611
| +501% | +$51.8K | 0.02% | 230 |
|
|
2023
Q4 | $9.72K | Hold |
122
| – | – | ﹤0.01% | 332 |
|
|
2023
Q3 | $8.68K | Hold |
122
| – | – | ﹤0.01% | 553 |
|
|
2023
Q2 | $9K | Hold |
122
| – | – | ﹤0.01% | 538 |
|
|
2023
Q1 | $9K | Hold |
122
| – | – | ﹤0.01% | 548 |
|
|
2022
Q4 | $10K | Hold |
122
| – | – | 0.01% | 497 |
|
|
2022
Q3 | $9K | Hold |
122
| – | – | ﹤0.01% | 514 |
|
|
2022
Q2 | $10K | Hold |
122
| – | – | ﹤0.01% | 508 |
|
|
2022
Q1 | $9K | Hold |
122
| – | – | ﹤0.01% | 566 |
|
|
2021
Q4 | $10K | Hold |
122
| – | – | ﹤0.01% | 569 |
|
|
2021
Q3 | $9K | Hold |
122
| – | – | ﹤0.01% | 583 |
|
|
2021
Q2 | $10K | Hold |
122
| – | – | ﹤0.01% | 559 |
|
|
2021
Q1 | $10K | Hold |
122
| – | – | ﹤0.01% | 544 |
|
|
2020
Q4 | $10K | Hold |
122
| – | – | 0.01% | 515 |
|
|
2020
Q3 | $10K | Hold |
122
| – | – | 0.01% | 505 |
|
|
2020
Q2 | $9K | Hold |
122
| – | – | 0.01% | 487 |
|
|
2020
Q1 | $9K | Hold |
122
| – | – | 0.01% | 482 |
|
|
2019
Q4 | $8K | Hold |
122
| – | – | 0.01% | 493 |
|
|
2019
Q3 | $9K | Hold |
122
| – | – | 0.01% | 455 |
|
|
2019
Q2 | $9K | Hold |
122
| – | – | 0.01% | 457 |
|
|
2019
Q1 | $8K | Hold |
122
| – | – | 0.01% | 478 |
|
|
2018
Q4 | $7K | Hold |
122
| – | – | 0.01% | 466 |
|
|
2018
Q3 | $8 | Hold |
122
| – | – | 0.01% | 452 |
|
|
2018
Q2 | $8 | Hold |
122
| – | – | 0.01% | 480 |
|
|
2018
Q1 | $9K | Sell |
122
-14,270
| -99% | -$1.03M | 0.01% | 449 |
|
|
2017
Q4 | $1.09M | Buy |
+14,392
| New | +$1.05M | 0.86% | 34 |
|
Other funds holding CL
VCM
DAM
VPM
Front Row Advisors's CL Position: Q1 2026 in Review
Front Row Advisors held its Colgate-Palmolive (CL) position steady in Q1 2026 at 733 shares worth $62.5K. The position accounts for 0.02% of the portfolio, ranked #205.
Front Row Advisors first reported a position in CL in Q4 2017 and has held it in 34 quarters since. The position peaked at $1.09M in Q4 2017. 1,945 funds tracked by Wall St. Rank hold CL as of Q1 2026.
- Front Row Advisors held 733 shares of Colgate-Palmolive worth $62.5K as of Q1 2026.
- Front Row Advisors left its Colgate-Palmolive share count unchanged in Q1 2026.
- Colgate-Palmolive made up 0.02% of Front Row Advisors's portfolio in Q1 2026, its #205 holding.
- Front Row Advisors first reported a position in Colgate-Palmolive in Q4 2017 and has held it in 34 quarters since.
- Front Row Advisors's Colgate-Palmolive position peaked at $1.09M in Q4 2017.
- 1,945 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.
Based on Front Row Advisors's 13F filing for Q1 2026, filed 19 May 2026.